1-6 of 6
Gabriel Afram
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of Elranatamab (ELRA) in Combination with Carfilzomib (CFZ) and Dexamethasone (DEX) in the Phase 1b MagnetisMM-20 Trial in Relapsed or Refractory Multiple Myeloma (RRMM)

Michael H. Tomasson, Eli Gabayan, Syed Abbas Ali, Gabriel Afram, Sona Ghorashi, Trish Creel, Luisa Paccagnella, Carolyn Lou, Ola Landgren
Journal: Blood
Blood (2024) 144 (Supplement 1): 1024.
https://doi.org/10.1182/blood-2024-210520
Published: 2024
Journal Articles

Outcomes of Relapsed and Refractory Multiple Myeloma with the Evolving Standard of Care

Vincent Luong, Muhammad Kashif, Katarina Uttervall, Anna Bohlin, Nursen Cetrez, Gabriel Afram, Hareth Nahi, Johan Lund, Evren Alici
Journal: Blood
Blood (2024) 144 (Supplement 1): 3320.
https://doi.org/10.1182/blood-2024-193255
Published: 2024
Journal Articles

CD38 Down-Regulation on Ex Vivo Activated and Expanded NK Cells for Cell Therapy Persists after Infusion

Hareth Nahi, Michael Chrobook, Stephan Meinke, Charlotte Gran, Nicole Marquardt, Gabriel Afram, Tolga Sutlu, Mari Gilljam, Birgitta Stellan, Arnika Kathleen Wagner, Lilian Walther-Jallow, Johan Liwing, Monika Klimkowska, Goesta Gahrton, Per Ljungman, Hans-Gustaf Ljunggren, Evren Alici
Journal: Blood
Blood (2021) 138 (Supplement 1): 4796.
https://doi.org/10.1182/blood-2021-152522
Published: 2021
Journal Articles

Thymic Function Predicts Response to Mesenchymal Stromal Cell Treatment in Chronic GvHD: A Phase II Clinical Study

Erik Boberg, Lena Von Bahr, MD PhD, Nina Heldring, PhD, Gabriel Afram, MD, Ellen Iacobaeus, MD PhD, Carina Lindström, RN, Karin Garming-Legert, DMD, PhD, Per Ljungman, Rachael Sugars, PhD, Lindsay Davies, MD PhD, Nadir Kadri, PhD, Katarina Le Blanc, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3253.
https://doi.org/10.1182/blood.V130.Suppl_1.3253.3253
Published: 2017
Journal Articles

Treatment of Chronic GvHD with Mesenchymal Stromal Cells Induces Durable Responses; A Phase II Study

Lena Von Bahr, MD, Lindsay Davies, PhD, Gabriel Afram, MD, Carina Modin, Karin Garming-Legert, PhD, Hans Hägglund, MD PhD, Per T. Ljungman, MD PhD, Katarina Le Blanc, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 3138.
https://doi.org/10.1182/blood.V126.23.3138.3138
Published: 2015
Journal Articles

Identification Of Patients At High Risk Of Chronic Graft-Versus-Host Disease: Gvhd Prophylaxis

Gabriel Afram, MD, Jose Antonio Pérez Simón, MD, PhD, Mats Remberger, PhD, Teresa Caballero-Velázquez, MD, PhD, Rodrigo Martino, MD, PhD, Jose Luis Piñana, MD, Olle Ringden, MD, Albert Esquirol, MD, Dolores Caballero, MD, PhD, Irene Garcia, MD, Lucía López-Corral, MD, PhD, Jordi Sierra, Oriana López-Godino, Per T. Ljungman, MD, PhD, Jesus F San Miguel, MD, PhD, Hans Hagglund, MD PhD
Journal: Blood
Blood (2013) 122 (21): 4611.
https://doi.org/10.1182/blood.V122.21.4611.4611
Published: 2013